Diabetic retinopathy screening
Screening for diabetic retinopathy, including autonomous AI.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 23, 20, 26, 31, 24.
New guidelines and consensus this year
All papers from the last 12 months
522 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Supportive care needs of patients with proliferative diabetic retinopathy: A qualitative studyInt J Nurs Stud Adv2026 DecPMID 42866644
- Using the Normalization Process Theory to study facilitators and barriers to sustainable implementation of artificial intelligence-based diabetic retinopathy screening in RwandaDialogues Health2026 DecPMID 42569249
- Beyond hyperglycaemia: diabetic retinopathy is a multifactorial complication of diabetes mellitusAnn Med2026 DecPMID 42499200Review
- A hybrid CNN-GNN and multitask learning pipeline for improving mild diabetic retinopathy sensitivityMethodsX2026 DecPMID 42436968
- Hybrid deep learning models for diabetic retinopathy stage classification using fundus imagesJ Diabetes Metab Disord2026 DecPMID 42381712
- The diagnostic accuracy of AI-assisted diabetic retinopathy screening in primary care: a prospective validation studyScand J Prim Health Care2026 DecPMID 42284159
- Design and validation of a responsible artificial intelligence-based system for the referral of diabetic retinopathy patientsHealth Inf Sci Syst2026 DecPMID 41399713
- Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular PhenotypeDiabetes Obes Metab2026 NovPMID 42477295Review
- Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapySurv Ophthalmol2026 Nov-DecPMID 42314860Review
- Disorganization of inner retinal layers and disruption of outer retinal layers as predictors of anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema: A scoping reviewSurv Ophthalmol2026 Nov-DecPMID 42176958
More ophthalmology trends
All specialties →Myopia control in children
Atropine drops, defocus lenses and orthokeratology to slow myopia.
Key point: In myopic children, atropine efficacy increased nonlinearly with concentration and may plateau, while higher doses were associated with decreased accommodation and photophobia.
Ischaemic optic neuropathy
Non-arteritic anterior ischaemic optic neuropathy, including reports linked to GLP-1 drugs.
Key point: In acute NAION, increased early optic nerve head swelling rates were associated with visual field and visual acuity worsening by month 6.
AI in retinal imaging
Deep learning on fundus photos and OCT, including signs of systemic disease.
Gene therapy for inherited retinal disease
Gene therapy and optogenetics for inherited retinal dystrophies.
Minimally invasive glaucoma surgery
MIGS devices and procedures.
Key point: Phaco-iStent and phaco-KDB both significantly reduced intraocular pressure and glaucoma medication burden with few postoperative complications.
Presbyopia drops
Eye drops that improve near vision in presbyopia.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"diabetic retinopathy"[tiab] AND screening[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.